Pancreatic Cancer Screening and Early Detection: Where Are We Now?

The authors examine the current state of pancreatic cancer screening and early detection, particularly for high-risk individuals, in light of the disease's poor prognosis due to late-stage diagnosis. They aim to evaluate existing screening strategies, emerging imaging technologies, and novel serum biomarkers that could enhance early detection and improve clinical outcomes. The paper highlights the need for validated, cost-effective tools to address the challenges in early diagnosis of pancreatic cancer.